Mears Group plc (LON:MER – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 374.08 ($4.71) and traded as high as GBX 375 ($4.73). Mears Group shares last traded at GBX 370 ($4.66), with a volume of 152,353 shares traded.
Mears Group Stock Performance
The stock has a market cap of £332.85 million, a P/E ratio of 902.44, a price-to-earnings-growth ratio of 0.68 and a beta of 1.26. The company has a quick ratio of 0.92, a current ratio of 0.87 and a debt-to-equity ratio of 137.41. The business has a 50 day moving average price of GBX 373.22 and a two-hundred day moving average price of GBX 374.08.
Insider Transactions at Mears Group
In other news, insider Andrew C. M. Smith purchased 12,018 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The stock was bought at an average cost of GBX 364 ($4.59) per share, with a total value of £43,745.52 ($55,129.83). Also, insider Lucas Critchley purchased 4,518 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were purchased at an average cost of GBX 362 ($4.56) per share, with a total value of £16,355.16 ($20,611.42). Corporate insiders own 2.76% of the company’s stock.
About Mears Group
Mears Group plc, together with its subsidiaries, provides various outsourced services to the public and private sectors in the United Kingdom. The company offers rapid-response and planned maintenance services to local authorities; gas and repair services; and maintenance and repairs, capital works, energy investment, and regeneration solutions for public buildings, as well as grounds maintenance services.
Recommended Stories
- Five stocks we like better than Mears Group
- Dividend Capture Strategy: What You Need to Know
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Stock Splits, Do They Really Impact Investors?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Mears Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mears Group and related companies with MarketBeat.com's FREE daily email newsletter.